EUVIMEDEUVIMED entdecken
Crossref

Extracorporeal Membrane Oxygenation: Rescue Therapy in Pediatric Bupropion Cardiotoxicity

Travis D. Olives, Christopher N. Sweat, Lauren Dorsey-Spitz, Farbod Bahadori-Esfahani, Ann M. Arens, Jon B. Cole, Arif Somani

Journal of Pediatric Intensive Care · 17.05.2024

DOI: 10.1055/s-0044-1786769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Intensive Care, erschienen am 17.05.2024. Verfasst von Travis D. Olives und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Our objective was to describe clinical characteristics and course of pediatric bupropion ingestions requiring extracorporeal membrane oxygenation (ECMO) life support. Desgin The study included a retrospective cohort of patients ≤18 years of age reported to a regional poison control (PC) system covering three states in the upper Midwest United States. All bupropion exposures ≤18 years of age, coded as receiving ECMO to treat toxicity, were included. Clinical presentation and management including ECMO are presented as descriptive statistics.

Results

During the study period, 4,951 bupropion exposures were reported; 1,145 (23.1%) were children. Nine patients were coded as undergoing ECMO; four (44.4%) were ≤18 years of age (median 16, range 14–17). All were treated with venoarterial ECMO. The median time from ingestion to presentation was 2.25 hours (range: 1–3.5). Median first systolic blood pressure and pulse were 100 mm Hg (range: 70–124) and 119.5 (range: 70–175). The median time from ingestion to ECMO was 17.63 hours (range: 7.25–33.75); median number of vasopressors was 2.5 (range: 2–3). All experienced multiple seizures, ventricular dysrhythmias, and hypotension. Three of four sustained cardiac arrest. All but one required transfer to an ECMO-capable facility for definitive care. Three patients survived with full neurologic recovery; one died.

Conclusion

Pediatric bupropion cases requiring ECMO were rare in this study. Time to initiation and duration of EMCO suggest that the variable onset of hemodynamic instability may delay ECMO initiation. It is incumbent on PCs and medical toxicologists to educate prescribers and pediatricians about bupropion's potential lethality and to consider early transfer to an ECMO center.

Zitieren

APA

Olives, T. D., Sweat, C. N., Dorsey-Spitz, L., Bahadori-Esfahani, F., Arens, A. M., Cole, J. B., & Somani, A. (2024). Extracorporeal Membrane Oxygenation: Rescue Therapy in Pediatric Bupropion Cardiotoxicity. Journal of Pediatric Intensive Care. https://doi.org/10.1055/s-0044-1786769

Vancouver

Olives TD, Sweat CN, Dorsey-Spitz L, Bahadori-Esfahani F, Arens AM, Cole JB, et al. Extracorporeal Membrane Oxygenation: Rescue Therapy in Pediatric Bupropion Cardiotoxicity. Journal of Pediatric Intensive Care. 2024. doi:10.1055/s-0044-1786769

BibTeX
@article{Olives2024,
  author = {Olives, Travis D. and Sweat, Christopher N. and Dorsey-Spitz, Lauren and Bahadori-Esfahani, Farbod and Arens, Ann M. and Cole, Jon B. and Somani, Arif},
  title = {Extracorporeal Membrane Oxygenation: Rescue Therapy in Pediatric Bupropion Cardiotoxicity},
  journal = {Journal of Pediatric Intensive Care},
  year = {2024},
  doi = {10.1055/s-0044-1786769}
}
Kostenlos starten →